Clinical Trials Browser

OTHER × Doxorubicin × Tumor-Agnostic × Clear all

NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Phase 2 Completed

54 enrolled 7 charts

Neoplasms

NCT00124956 2017-09-11

Doxorubicin Pharmacokinetic (PK) Study

Phase 1/2 Withdrawn

Neoplasms